WHO ICTRP trial
A Double-blind, Randomised, 4-arm Parallel Group, Multicentre, 8-week, Phase III…
EUCTR2006-003963-30-EE · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2006-003963-30-EE |
|---|---|
| Public title | A Double-blind, Randomised, 4-arm Parallel Group, Multicentre, 8-week, Phase III Study to Assess the Antihypertensive Efficacy and Safety of the Combination of Candesartan Cilexetil 32 mg and Hydrochlorothiazide 25 mg in Comparison with Candesartan Cilexetil 32 mg, Hydrochlorothiazide 25 mg and Placebo in Hypertensive Adults. |
| Scientific title | A Double-blind, Randomised, 4-arm Parallel Group, Multicentre, 8-week, Phase III Study to Assess the Antihypertensive Efficacy and Safety of the Combination of Candesartan Cilexetil 32 mg and Hydrochlorothiazide 25 mg in Comparison with Candesartan Cilexetil 32 mg, Hydrochlorothiazide 25 mg and… |
| Primary sponsor | AstraZeneca AB |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Hungary;Malta;Estonia;Latvia;Lithuania |
| Conditions | Hypertension MedDRA version: 9 Level: LLT Classification code 10020772 |
| Interventions | Trade Name: Atacand Plus Product Name: Candesartan cilexetil/hydrochlorothiazide 16/12.5 mg Pharmaceutical Form: Tablet INN or Proposed INN: Candesartan cilexetil Concentration unit: mg milligram(s) Concentration type: equal Concentration… |
| Registration date | Oct 18, 2006 |
| Target size | 2000 |
| Secondary IDs | D2456C00002 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: